233 related articles for article (PubMed ID: 8673127)
1. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency.
Hirschhorn R; Yang DR; Puck JM; Huie ML; Jiang CK; Kurlandsky LE
Nat Genet; 1996 Jul; 13(3):290-5. PubMed ID: 8673127
[TBL] [Abstract][Full Text] [Related]
2. Somatic mosaicism for a newly identified splice-site mutation in a patient with adenosine deaminase-deficient immunodeficiency and spontaneous clinical recovery.
Hirschhorn R; Yang DR; Israni A; Huie ML; Ownby DR
Am J Hum Genet; 1994 Jul; 55(1):59-68. PubMed ID: 8023852
[TBL] [Abstract][Full Text] [Related]
3. Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype.
Santisteban I; Arredondo-Vega FX; Kelly S; Mary A; Fischer A; Hummell DS; Lawton A; Sorensen RU; Stiehm ER; Uribe L
J Clin Invest; 1993 Nov; 92(5):2291-302. PubMed ID: 8227344
[TBL] [Abstract][Full Text] [Related]
4. Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).
Hirschhorn R; Yang DR; Insel RA; Ballow M
Cell Immunol; 1993 Dec; 152(2):383-93. PubMed ID: 8258146
[TBL] [Abstract][Full Text] [Related]
5. Somatic mosaicism caused by monoallelic reversion of a mutation in T cells of a patient with ADA-SCID and the effects of enzyme replacement therapy on the revertant phenotype.
Moncada-Vélez M; Vélez-Ortega A; Orrego J; Santisteban I; Jagadeesh J; Olivares M; Olaya N; Hershfield M; Candotti F; Franco J
Scand J Immunol; 2011 Nov; 74(5):471-81. PubMed ID: 21671975
[TBL] [Abstract][Full Text] [Related]
6. Carrier frequency of a nonsense mutation in the adenosine deaminase (ADA) gene implies a high incidence of ADA-deficient severe combined immunodeficiency (SCID) in Somalia and a single, common haplotype indicates common ancestry.
Sanchez JJ; Monaghan G; Børsting C; Norbury G; Morling N; Gaspar HB
Ann Hum Genet; 2007 May; 71(Pt 3):336-47. PubMed ID: 17181544
[TBL] [Abstract][Full Text] [Related]
7. Female germ line mosaicism as the origin of a unique IL-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency.
Puck JM; Pepper AE; Bédard PM; Laframboise R
J Clin Invest; 1995 Feb; 95(2):895-9. PubMed ID: 7860773
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of adenosine deaminase deficiency.
Markert ML
Immunodeficiency; 1994; 5(2):141-57. PubMed ID: 8032366
[TBL] [Abstract][Full Text] [Related]
9. Genotype is an important determinant of phenotype in adenosine deaminase deficiency.
Hershfield MS
Curr Opin Immunol; 2003 Oct; 15(5):571-7. PubMed ID: 14499267
[TBL] [Abstract][Full Text] [Related]
10. Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency.
Shovlin CL; Simmonds HA; Fairbanks LD; Deacock SJ; Hughes JM; Lechler RI; Webster AD; Sun XM; Webb JC; Soutar AK
J Immunol; 1994 Sep; 153(5):2331-9. PubMed ID: 8051429
[TBL] [Abstract][Full Text] [Related]
11. Identification of a point mutation in the adenosine deaminase gene responsible for immunodeficiency.
Bonthron DT; Markham AF; Ginsburg D; Orkin SH
J Clin Invest; 1985 Aug; 76(2):894-7. PubMed ID: 3839802
[TBL] [Abstract][Full Text] [Related]
12. [Genetic analysis of two patients with adenosine deaminase (ADA)-deficiency: detection of three novel mutations and characterization of two paradoxical carriers].
Oda N; Ariga T; Ono S; Kobayashi I; Kawamura N; Okano M; Kobayashi Y; Taniuchi S; Terada K; Kataoka N; Sakiyama Y
Arerugi; 2000 Dec; 49(12):1173-80. PubMed ID: 11197883
[TBL] [Abstract][Full Text] [Related]
13. Adenosine deaminase deficiency with mosaicism for a "second-site suppressor" of a splicing mutation: decline in revertant T lymphocytes during enzyme replacement therapy.
Arredondo-Vega FX; Santisteban I; Richard E; Bali P; Koleilat M; Loubser M; Al-Ghonaium A; Al-Helali M; Hershfield MS
Blood; 2002 Feb; 99(3):1005-13. PubMed ID: 11807006
[TBL] [Abstract][Full Text] [Related]
14. [Gene therapy for adenosine deaminase deficiency].
Sakiyama Y
Hokkaido Igaku Zasshi; 1996 Jan; 71(1):27-32. PubMed ID: 8727372
[TBL] [Abstract][Full Text] [Related]
15. Identification of two new missense mutations (R156C and S291L) in two ADA- SCID patients unusual for response to therapy with partial exchange transfusions.
Hirschhorn R
Hum Mutat; 1992; 1(2):166-8. PubMed ID: 1284479
[No Abstract] [Full Text] [Related]
16. A point mutation in the 5' splice region of intron 7 causes a deletion of exon 7 in adenosine deaminase mRNA.
Kawamoto H; Ito K; Kashii S; Monden S; Fujita M; Norioka M; Sasai Y; Okuma M
J Cell Biochem; 1993 Mar; 51(3):322-5. PubMed ID: 8501134
[TBL] [Abstract][Full Text] [Related]
17. Correct splicing despite mutation of the invariant first nucleotide of a 5' splice site: a possible basis for disparate clinical phenotypes in siblings with adenosine deaminase deficiency.
Arredondo-Vega FX; Santisteban I; Kelly S; Schlossman CM; Umetsu DT; Hershfield MS
Am J Hum Genet; 1994 May; 54(5):820-30. PubMed ID: 8178821
[TBL] [Abstract][Full Text] [Related]
18. Five missense mutations at the adenosine deaminase locus (ADA) detected by altered restriction fragments and their frequency in ADA--patients with severe combined immunodeficiency (ADA-SCID).
Hirschhorn R; Ellenbogen A; Tzall S
Am J Med Genet; 1992 Jan; 42(2):201-7. PubMed ID: 1346349
[TBL] [Abstract][Full Text] [Related]
19. Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency.
Bollinger ME; Arredondo-Vega FX; Santisteban I; Schwarz K; Hershfield MS; Lederman HM
N Engl J Med; 1996 May; 334(21):1367-71. PubMed ID: 8614422
[No Abstract] [Full Text] [Related]
20. A phenotypically normal revertant of an adenosine deaminase-deficient lymphoblast cell line.
Uberti J; Peterson WD; Lightbody JJ; Johnson RM
J Immunol; 1983 Jun; 130(6):2866-70. PubMed ID: 6854019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
